(Q77769272)

English

Autocrine costimulation: tumor-specific CD28-mediated costimulation of T cells by in situ production of a bifunctional B7-anti-CEA diabody fusion protein

scientific article published on 01 March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896444%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Autocrine costimulation: tumor-specific CD28-mediated costimulation of T cells by in situ production of a bifunctional B7-anti-CEA diabody fusion protein (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896444%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Belén Blanco

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896444%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Philipp Holliger

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896444%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Luis Alvarez-Vallina

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896444%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896444%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896444%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896444%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896444%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

275-281

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896444%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700438

0 references

Antigen recognition by class I-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700438

7 January 2021

based on heuristic

inferred from DOI database lookup

The ups and downs of T cell costimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700438

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700438

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700438

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of the CD28 receptor during T cell responses to antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700438

7 January 2021

based on heuristic

inferred from DOI database lookup

CD28-B7 interactions in T-cell activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700438

7 January 2021

based on heuristic

inferred from DOI database lookup

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700438

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700438

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700438

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700438

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700438

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic approaches for antigen-selective cell therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700438

7 January 2021

based on heuristic

inferred from DOI database lookup

Engineering and characterization of a novel fusion protein incorporating B7.2 and an anti-ErbB-2 single-chain antibody fragment for the activation of Jurkat T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700438

7 January 2021

based on heuristic

inferred from DOI database lookup

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700438

7 January 2021

based on heuristic

inferred from DOI database lookup

T cell targeting in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700438

7 January 2021

based on heuristic

inferred from DOI database lookup

"Diabodies": small bivalent and bispecific antibody fragments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700438

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700438

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896444%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896444%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77769272&oldid=1465507757"